Breaking News

Abzena Welcomes Dr. Moncef Slaoui to Its Board of Directors

Slaoui is an accomplished leader in the biopharmaceutical industry with 40+ years of experience.

Author Image

By: Charlie Sternberg

Associate Editor

Abzena, an end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has appointed Moncef Slaoui, PhD, to its Board of Directors. An accomplished leader in the biopharmaceutical industry with over 40 years of experience, Dr. Slaoui has held numerous executive leadership and board-level positions to help drug development companies through high phases of growth. Matt Stober, CEO of Abzena said, “Dr. Slaoui’s exceptional track record of leadership and expertise in product inno...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics